Skip to main content

MoneyWorks4Me

The sales is pegged at Rs. 472.34 millions for the December 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 601.40 millions during the year-ago period.The Net Profit of the company slipped to Rs. 39.63 millions from Rs. 77.85 millions, a decline of -49.09% on QoQ basis.Operating Profit reported a sharp decline to 59.17 millions from 103.75 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 472.34 601.40 -21.46 1652.16 1812.63 -8.85 2367.14 2175.84 8.79
Other Income 25.21 17.41 44.80 67.92 31.76 113.85 57.34 34.27 67.32
PBIDT 59.17 103.75 -42.97 271.90 318.90 -14.74 398.85 284.55 40.17
Interest 2.26 1.77 27.68 5.97 2.17 175.12 4.13 2.85 44.91
PBDT 56.91 101.98 -44.19 265.93 282.14 -5.75 360.13 281.70 27.84
Depreciation 4.12 3.30 24.85 12.60 7.27 73.31 12.05 15.26 -21.04
PBT 52.79 98.68 -46.50 253.33 274.87 -7.84 348.08 266.44 30.64
TAX 13.16 20.83 -36.82 64.19 63.69 0.79 80.87 77.87 3.85
Deferred Tax -0.56 10.13 -105.53 -1.37 2.77 -149.46 4.56 3.84 18.75
PAT 39.63 77.85 -49.09 189.14 211.18 -10.44 267.21 188.57 41.70
Equity 131.44 130.99 0.34 131.44 130.99 0.34 130.99 130.99 0.00
PBIDTM(%) 12.53 17.25 -27.39 16.46 17.59 -6.46 16.85 13.08 28.84
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..